The FDA's Category 2 designation means the substance may present significant safety risks when used in compounding and is prohibited in compounded medications pending further evaluation
Side Effects Of VITNEURIN INJECTION Common Skin irritation and/or pain around the injection area Bruising around the injection site Mild nausea, vomiting, abdominal pain, or loss of appetite Headache or sleepiness Numbness in the hands or feet, clumsiness, or difficulty walking Hives Heartburn Fatigue Sore throat Rare Stop receiving VITNEURIN Injection and consult your doctor immediately if you experience any of the following side effects: Symptoms of an allergic reaction may include skin rash, itchiness, nausea, sweating, a feeling of warmth, tingling, weakness, tightness of the throat, pain in the chest, a fast heartbeat, difficulty breathing, faintness or swelling of the lips, face, tongue, throat, hands, or feet Severe pain or inflammation of the feet, knees, hands, or elbows Sneezing Flushing, severe rash, temporary itchiness Blue discolouration of the skin Bleeding Prolonged stomach pain Severe dizziness or drowsiness Muscular paralysis Low blood pressure Prolonged nausea or vomiting Restlessness Scaling of the facial skin Inability to focus the eyes How To Manage Side Effects Headache Rest and relax
Research has studied ARA-290 for its cytoprotective, anti-inflammatory, and neuroprotective properties in models of ischemia, neuropathic pain, and metabolic tissue injury
Across all respondents who microdosed, 24 percent said they had been microdosing for six months or more, showing it may be a more sustainable way to tackle weight loss goals
While more human studies are needed, existing peptide research suggests strong potential for improving flexibility, reducing discomfort, and helping the body heal more efficiently
